Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts


  Free Subscription


1 Am J Epidemiol
1 Diabetes Care
2 PLoS Genet
8 PLoS One
1 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Epidemiol

  1. CHANG VW, Alley DE, Dowd JB
    Trends in the Relationship of Obesity and Disability, 1988-2012.
    Am J Epidemiol. 2017 May 9. doi: 10.1093.
    PubMed     Text format     Abstract available

    Diabetes Care

  2. STEINBERG WM, Rosenstock J, Wadden TA, Donsmark M, et al
    Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program.
    Diabetes Care. 2017 May 4. pii: dc162684. doi: 10.2337/dc16-2684.
    PubMed     Text format     Abstract available

    PLoS Genet

  3. SERRA-JUHE C, Martos-Moreno GA, Bou de Pieri F, Flores R, et al
    Novel genes involved in severe early-onset obesity revealed by rare copy number and sequence variants.
    PLoS Genet. 2017;13:e1006657.
    PubMed     Text format     Abstract available

  4. ISLES AR, Ingason A, Lowther C, Walters J, et al
    Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders.
    PLoS Genet. 2016;12:e1005993.
    PubMed     Text format     Abstract available

    PLoS One

  5. KANG YM, Jung CH, Cho YK, Lee SE, et al
    Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.
    PLoS One. 2017;12:e0175762.
    PubMed     Text format     Abstract available

  6. REYNOLDS TH 4TH, Soriano RA, Obadi OA, Murkland S, et al
    Long term rebaudioside A treatment does not alter circadian activity rhythms, adiposity, or insulin action in male mice.
    PLoS One. 2017;12:e0177138.
    PubMed     Text format     Abstract available

  7. RESTIVO MR, McKinnon MC, Frey BN, Hall GB, et al
    The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder.
    PLoS One. 2017;12:e0176898.
    PubMed     Text format     Abstract available

  8. TSUTSUMI J, Minai K, Kawai M, Ogawa K, et al
    Manifold implications of obesity in ischemic heart disease among Japanese patients according to covariance structure analysis: Low reactivity of B-type natriuretic peptide as an intervening risk factor.
    PLoS One. 2017;12:e0177327.
    PubMed     Text format     Abstract available

  9. MACHIDA T, Takata F, Matsumoto J, Miyamura T, et al
    Contribution of thrombin-reactive brain pericytes to blood-brain barrier dysfunction in an in vivo mouse model of obesity-associated diabetes and an in vitro rat model.
    PLoS One. 2017;12:e0177447.
    PubMed     Text format     Abstract available

  10. LASSALLE M, Fezeu LK, Couchoud C, Hannedouche T, et al
    Obesity and access to kidney transplantation in patients starting dialysis: A prospective cohort study.
    PLoS One. 2017;12:e0176616.
    PubMed     Text format     Abstract available

  11. BIWER C, Rothberg A, IglayReger H, Derksen H, et al
    Windowed persistent homology: A topological signal processing algorithm applied to clinical obesity data.
    PLoS One. 2017;12:e0177696.
    PubMed     Text format     Abstract available

  12. BRANSCHEIDT M, Schneider J, Michel P, Eskioglou E, et al
    No Impact of Body Mass Index on Outcome in Stroke Patients Treated with IV Thrombolysis BMI and IV Thrombolysis Outcome.
    PLoS One. 2016;11:e0164413.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  13. HOOTMAN KC, Trezzi JP, Kraemer L, Burwell LS, et al
    Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults.
    Proc Natl Acad Sci U S A. 2017 May 8. pii: 201620079.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.